글로벌감염병센터

최신연구자료

비회원이 작성한 글입니다!

글작성시 입력했던 비밀번호를 입력해주세요.

List Next Prev
게시글 내용
A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus 출혈열 바이러스-Hemorrhagic Fever Virus
2018/08/09

 

A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus

 

Authors:

Gunn et al.

  


Summary:

The recent Ebola virus (EBOV) epidemic highlighted the need for effective vaccines and therapeutics to limit and prevent outbreaks. Host antibodies against EBOV are critical for controlling disease, and recombinant monoclonal antibodies (mAbs) can protect from infection. However, antibodies mediate an array of antiviral functions including neutralization as well as engagement of Fc-domain receptors on immune cells, resulting in phagocytosis or NK cell-mediated killing of infected cells. Thus, to understand the antibody features mediating EBOV protection, we examined specific Fc features associated with protection using a library of EBOV-specific mAbs. Neutralization was strongly associated with therapeutic protection against EBOV. However, several neutralizing mAbs failed to protect, while several non-neutralizing or weakly neutralizing mAbs could protect. Antibody-mediated effector functions, including phagocytosis and NK cell activation, were associated with protection, particularly for antibodies with moderate neutralizing activity. This framework identifies functional correlates that can inform therapeutic and vaccine design strategies against EBOV and other pathogens.

  

 

Source:

Cell Host & Microbe - Aug 08, 2018

24|2|Pages 221-233.e5

DOI: 10.1016/j.chom.2018.07.009

DOI: https://doi.org/10.1016/j.chom.2018.07.009

August 08, 2018 | Volume 24 | Issue 2

© 2018 Elsevier Inc.

 

List Next Prev
TOP